SCHEMBL9504118

SCHEMBL9504118

CC(C)c1cccc(C(C)C)c1NC(=O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
KMT2A Q03164 1/20 0.58
LPAR1 Q92633 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9723518 0.93 LMNA (0.54) LMNAKMT2ALPAR1
SCHEMBL9844414 0.84 SOAT1 (0.58) LMNAKMT2A
SCHEMBL9848451 0.81 LMNA (0.51) LMNAKMT2ALPAR1
SCHEMBL462304 0.81 LPAR1 (0.66) LMNAKMT2ALPAR1
SCHEMBL7573234 0.80 NLRP3 (0.54)
SCHEMBL7567348 0.80
SCHEMBL9844254 0.80 SOAT1 (0.55) KMT2A
SCHEMBL9504026 0.80 SOAT2 (0.57)
SCHEMBL8321568 0.79
SCHEMBL9678841 0.79 KMT2A (0.55) LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335374-B1 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1993-06-30 EP claimed
US-5116848-A N-(((2,6-DISUBSTITUTED)PHENYL)-N-DIARYLALKYL)UREAS AS ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS WARNER-LAMBERT COMPANY (US) 1992-05-26 US claimed
EP-0335374-B1 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1993-06-30 EP disclosed
US-5116848-A N-(((2,6-DISUBSTITUTED)PHENYL)-N-DIARYLALKYL)UREAS AS ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS WARNER-LAMBERT COMPANY (US) 1992-05-26 US disclosed
EP-0335374-A2 N-[[(2,6-disubstituted)phenyl]-N'-diarylalkyl] ureas as antihyperlipidemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-10-04 EP disclosed